Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director Director departure
|
ChemoCentryx, Inc. (CCXI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/12/2022 |
SC 13G/A
| FMR LLC reports a 0% stake in CHEMOCENTRYX INC |
02/14/2022 |
SC 13G/A
| Schall Thomas J. reports a 6.5% stake in ChemoCentryx, Inc. |
02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in ChemoCentryx, Inc. |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2022 |
SC 13G/A
| FMR LLC reports a 15% stake in CHEMOCENTRYX INC |
02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
06/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Schall Thomas J. reports a 6.3% stake in ChemoCentryx, Inc. |
02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Schall Thomas J. reports a 8% stake in ChemoCentryx, Inc. |
02/07/2020 |
SC 13G/A
| FMR LLC reports a 15% stake in CHEMOCENTRYX INC |
05/10/2019 |
SC 13G/A
| BlackRock Inc. reports a 4.7% stake in CHEMOCENTRYX, INC |
04/15/2019 |
SC 13G/A
| BIO-TECHNE Corp reports a 7.2% stake in ChemoCentryx, Inc. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Schall Thomas J. reports a 9.1% stake in ChemoCentryx, Inc. |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
02/13/2017 |
SC 13G/A
| Schall Thomas J. reports a 8.8% stake in ChemoCentryx, Inc. |
02/10/2017 |
SC 13G/A
| ChemoCentryx, Inc. reports a 4.4% stake in ChemoCentryx, Inc. |
02/16/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/16/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/05/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
08/31/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|